61 related articles for article (PubMed ID: 1651897)
1. Modifications in bone-GLA protein (BGP) and aminoterminal propeptide of type III procollagen (PIIINP) levels in one patient with Cushing's syndrome.
Sartorio A; Ambrosi B; Conti A; Monzani M; Faglia G
Horm Metab Res; 1991 May; 23(5):247-9. PubMed ID: 1651897
[No Abstract] [Full Text] [Related]
2. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.
Piovesan A; Terzolo M; Reimondo G; Pia A; Codegone A; Osella G; Boccuzzi A; Paccotti P; Angeli A
Horm Metab Res; 1994 May; 26(5):234-7. PubMed ID: 8076906
[TBL] [Abstract][Full Text] [Related]
3. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing's disease.
Guo W; Li F; Zhu C; Wang B; Wang K; Dai C; Jia H; Wei H; He Q; Cui J; Yuan M; Tang S; Liu W; Zhu T; Gao Z; Zheng F; Ma Z; Qu H; Zhu M
J Int Med Res; 2018 Jan; 46(1):492-503. PubMed ID: 28851260
[TBL] [Abstract][Full Text] [Related]
6. [Blood levels of beta-endorphin and beta-lipotropin in patients with Cushing's syndrome].
Slavnov VN; Valueva GV; Luchitskiĭ EV; Iakovlev AA
Ter Arkh; 1981; 53(12):107-10. PubMed ID: 6278666
[No Abstract] [Full Text] [Related]
7. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
8. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
9. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
Zachariae H; Halkier-Sørensen L; Heickendorff L
Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
[TBL] [Abstract][Full Text] [Related]
10. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
[TBL] [Abstract][Full Text] [Related]
11. Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas.
Osella G; Terzolo M; Reimondo G; Piovesan A; Pia A; Termine A; Paccotti P; Angeli A
J Clin Endocrinol Metab; 1997 Oct; 82(10):3303-7. PubMed ID: 9329358
[TBL] [Abstract][Full Text] [Related]
12. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
Joffe P; Heaf JG; Jensen LT
Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
[TBL] [Abstract][Full Text] [Related]
13. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
14. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
[TBL] [Abstract][Full Text] [Related]
16. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma.
Sartorio A; Conti A; Ferrero S; Giambona S; Re T; Passini E; Ambrosi B
Eur J Endocrinol; 1998 Feb; 138(2):146-52. PubMed ID: 9506857
[TBL] [Abstract][Full Text] [Related]
18. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
[TBL] [Abstract][Full Text] [Related]
19. Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.
Kröger H; Risteli J; Risteli L; Penttilä I; Alhava E
Ann Rheum Dis; 1993 May; 52(5):338-42. PubMed ID: 8323381
[TBL] [Abstract][Full Text] [Related]
20. Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome.
Sartorio A; Conti A; Ferrario S; Passini E; Re T; Ambrosi B
Postgrad Med J; 1996 Jul; 72(849):419-22. PubMed ID: 8935602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]